Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Distinct Exosomal miRNA Profiles from BALF and Lung Tissue from COPD and IPF Patients

Version 1 : Received: 25 August 2021 / Approved: 27 August 2021 / Online: 27 August 2021 (11:33:42 CEST)

How to cite: Kaur, G.; Maremanda, K.; Campos, M.; Chand, H.S.; Li, F.; Hirani, N.; Haseeb, M.A.; Rahman, I. Distinct Exosomal miRNA Profiles from BALF and Lung Tissue from COPD and IPF Patients. Preprints 2021, 2021080520 (doi: 10.20944/preprints202108.0520.v1). Kaur, G.; Maremanda, K.; Campos, M.; Chand, H.S.; Li, F.; Hirani, N.; Haseeb, M.A.; Rahman, I. Distinct Exosomal miRNA Profiles from BALF and Lung Tissue from COPD and IPF Patients. Preprints 2021, 2021080520 (doi: 10.20944/preprints202108.0520.v1).

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) and Idiopathic Pulmonary Fibrosis (IPF) are chronic, progressive lung ailments which are characterized by distinct pathologies. Early detection biomarkers and disease mechanisms for these debilitating diseases are lacking. Exosomes are small extracellular vesicles attributed to carry proteins, mRNA, miRNA and sncRNA to facilitate cell-to-cell communication under normal and diseased conditions. Exosomal miRNAs have been studied in relation to many diseases. However, there is little to no knowledge regarding the miRNA population of BALF or the lung tissue derived exosomes in COPD and IPF. Here, we determined and compared the miRNA profiles of BALF and lung tissue-derived exosomes from healthy non-smokers, healthy smokers, and patients with COPD and IPF in independent cohorts. Results: Exosome characterization using NanoSight particle tracking and TEM demonstrated that the BALF-derived exosomes were approximately 89.85 nm in size and ~2.95 X 1010 particles/mL. Lung-derived exosomes were ~146.04 nm in size and ~2.38 X 1011 particles/mL. NGS results identified three differentially expressed miRNAs in the BALF, while one in the lung-derived exosomes from COPD patients as compared to healthy non-smokers. Of these, three- and five-fold downregulation of miR-122-5p amongst the lung tissue-derived exosomes from COPD patients as compared to healthy non-smokers and smokers, respectively. Interestingly, there were key 55 differentially expressed miRNAs in the lung tissue-derived exosomes of IPF patients compared to non-smoking controls. Conclusions: Overall, we identified specific miRNAs to develop as biomarkers or targets for pathogenesis of these chronic lung diseases.

Keywords

Exosomes; COPD; smokers; IPF; BALF; lung

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.